Sofinnova Investments, Inc.
Menlo Park, CA · CIK 1631134 · 13F filing filed 2026-08-14
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
- Legal entitySOFINNOVA INVESTMENTS, INC. (US)
- Kindhedge funds, venture
- Others nearbyMenlo Park, CA, Atherton, CA, Boston, MA, New York, NY, Montréal
- FamilySofinnova Investments, Inc. · 2 related pages
As an employer
US visa salary filings
- Filings FY20241
- Median salary offered$150,000
- Middle half$150,000 – $150,000
- Job titles1
| Job title | Filings | Median |
|---|---|---|
| Financial AnalystMenlo Park, CA | 1 | $150,000 |
Source: US Department of Labor, Labor Condition Application disclosure data (certified, full-time, yearly equivalent). These are the salaries the employer committed to pay the visa roles it filed for, at least the prevailing wage for the job and place; they are not the pay of all its staff. Filed by: Sofinnova Investments, Inc..
Options: 3 call positions ($48.4m notional), 1 put positions ($13.8m notional) – listed below, not included above.
Holdings, Q2 2026
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| NATERA INC NTRA | $420.8m22.48% | Unchanged |
| VERA THERAPEUTICS INC VERA | $119.9m6.40% | Unchanged |
| GENMAB A/S GMAB | $111.1m5.94% | Added +3.3m |
| JAZZ PHARMACEUTICALS PLC JAZZ | $88.0m4.70% | Reduced -233.0k |
| RAPPORT THERAPEUTICS INC RAPP | $79.4m4.24% | Unchanged |
| SEAPORT THERAPEUTICS INC SPTX | $77.4m4.14% | New |
| ARRIVENT BIOPHARMA INC AVBP | $58.9m3.15% | Unchanged |
| ULTRAGENYX PHARMACEUTICAL IN RARE | $57.3m3.06% | Reduced -1.4m |
| BIOAGE LABS INC BIOA | $56.2m3.00% | Unchanged |
| BRISTOL-MYERS SQUIBB CO BMY | $50.5m2.70% | Reduced -1.1m |
| SUPERNUS PHARMACEUTICALS INC SUPN | $48.2m2.57% | Added +82.0k |
| RHYTHM PHARMACEUTICALS INC RYTM | $45.3m2.42% | Reduced -42.1k |
| GILEAD SCIENCES INC GILD | $43.3m2.32% | New |
| UNITED THERAPEUTICS CORP DEL UTHR | $41.4m2.21% | Reduced -83.6k |
| COGENT BIOSCIENCES INC COGT | $40.1m2.14% | Reduced -1.1m |
| AXSOME THERAPEUTICS INC AXSM | $39.3m2.10% | Reduced -52.3k |
| IMMATICS N.V IMTX | $37.2m1.99% | Added +38.9k |
| DYNE THERAPEUTICS INC DYN | $36.8m1.97% | Added +24.5k |
| IMMUNOME INC IMNM | $36.5m1.95% | Added +18.4k |
| IDEAYA BIOSCIENCES INC IDYA | $34.5m1.84% | Reduced -206.7k |
| ANAPTYSBIO INC ANAB | $33.3m1.78% | Added +245.3k |
| NEKTAR THERAPEUTICS NKTR | $32.9m1.76% | Reduced -37.8k |
| PHARVARIS N V PHVS | $30.5m1.63% | Added +63.0k |
| ARCUS BIOSCIENCES INC RCUS | $29.2m1.56% | Added +22.6k |
| INHIBRX BIOSCIENCES INC INBX | $28.7m1.53% | Reduced -102.9k |
| BIOMARIN PHARMACEUTICAL INC BMRN | $20.5m1.10% | Reduced -423.4k |
| VERADERMICS INC MANE | $18.3m0.98% | Added +75.7k |
| ALCON AG ALC | $17.2m0.92% | Reduced -474.1k |
| INSMED INC INSM | $16.9m0.90% | Reduced -187.7k |
| EDGEWISE THERAPEUTICS INC EWTX | $15.5m0.83% | Reduced -5.6k |
| NURIX THERAPEUTICS INC NRIX | $12.7m0.68% | New |
| DESIGN THERAPEUTICS INC DSGN | $12.5m0.67% | New |
| DEFINIUM THERAPEUTICS INC DFTX | $12.0m0.64% | Reduced -88.3k |
| FIRST TRACKS BIOTHERAPEUTICS TRAX | $11.4m0.61% | New |
| ABBOTT LABS ABT | $11.2m0.60% | New |
| DISC MEDICINE INC IRON | $10.7m0.57% | Added +67.9k |
| TENAX THERAPEUTICS INC TENX | $7.3m0.39% | Added +395.6k |
| SIONNA THERAPEUTICS INC SION | $6.4m0.34% | New |
| ABSCI CORPORATION ABSI | $3.9m0.21% | New |
| MIRUM PHARMACEUTICALS INC MIRM | $3.2m0.17% | Unchanged |
| JADE BIOSCIENCES INC JBIO | $2.4m0.13% | Unchanged |
| SAVARA INC SVRA | $2.2m0.12% | Unchanged |
| PRAXIS PRECISION MEDICINES I PRAX | $2.2m0.12% | Reduced -57.2k |
| SEPTERNA INC SEPN | $1.6m0.08% | Unchanged |
| ONKURE THERAPEUTICS INC OKUR | $1.5m0.08% | Added +180.0k |
| SAGIMET BIOSCIENCES INC SGMT | $1.3m0.07% | New |
| WAVE LIFE SCIENCES LTD 96663EUR | $1.1m0.06% | Unchanged |
| AKTIS ONCOLOGY INC AKTS | $1.0m0.06% | New |
| TYRA BIOSCIENCES INC TYRA | $1.0m0.06% | Reduced -171.7k |
| BOLT BIOTHERAPEUTICS INC BOLT | $530.2k0.03% | Unchanged |
| NEXTCURE INC NXTC | $356.2k0.02% | Unchanged |
| IMAGENEBIO INC IMA | $188.1k0.01% | Unchanged |
| HEARTFLOW INC HTFL | $149.0k0.01% | New |
Sold out since Q1 2026
| Security | Value then |
|---|---|
| ASTRAZENECA PLC AZN | $89.9m456.0k shares |
| BIOGEN INC BIIB | $42.1m229.5k shares |
| CELCUITY INC CELC | $41.8m366.2k shares |
| BRIDGEBIO PHARMA INC BBIO | $30.4m409.2k shares |
| DEXCOM INC DXCM | $24.7m393.6k shares |
| XENON PHARMACEUTICALS INC XENE | $17.7m305.2k shares |
| STRYKER CORPORATION SYK | $14.6m44.5k shares |
| ROIVANT SCIENCES LTD ROIV | $13.2m478.0k shares |
| COMPASS THERAPEUTICS INC CMPX | $10.9m2.1m shares |
| ORIC PHARMACEUTICALS INC ORIC | $8.6m679.6k shares |
| TANGO THERAPEUTICS INC TNGX | $8.3m395.1k shares |
| AXOGEN INC AXGN | $7.0m210.7k shares |
| CYTOKINETICS INC CYTK | $6.0m91.8k shares |
| HARMONY BIOSCIENCES HLDGS IN HRMY | $4.3m152.7k shares |
| VAXCYTE INC PCVX | $2.9m50.6k shares |
| ESTABLISHMENT LABS HLDGS INC ESTA | $1.9m33.9k shares |
| ACADIA PHARMACEUTICALS INC ACAD | $1.7m78.6k shares |
| SOLENO THERAPEUTICS INC SLNO | $491.8k14.7k shares |
| ZYMEWORKS INC ZYME | $40.3k1.6k shares |
Options (notional value)
| Underlying | Notional | Change |
|---|---|---|
| ULTRAGENYX PHARMACEUTICAL IN RARE · Call | $16.7m500.0k shares | Added |
| INTUITIVE SURGICAL INC ISRG · Call | $15.9m40.0k shares | New |
| GLOBUS MED INC GMED · Call | $15.8m200.0k shares | New |
| EXELIXIS INC EXEL · Put | $13.8m254.2k shares | Added |